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SUMMARY
Infective endocarditis was a fatal disease three generations ago. Temporal evolution of 
knowledge made possible important advances in diagnostic techniques, specially in 
echocardiography, the possibility of cardiac surgery during the active infeccious process 
and new guidelines for antibiotic prophylaxis before interventional procedures. Nowa-
days infective endocarditis is curable. In this review we describe historical aspects of en-
docarditis since Osler´s observations in the 19th century until the change from a “clini-
cally possible” to a “clinically definite” disease.
Keywords: Endocarditis, bacterial; cultural characteristics; outcome assessment (health 
care).
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INTRODUCTION
“ The infective endocarditis increases the physician’s   
interest in the development of an infectious process”.
William Bart Osler, 1893
Looking at Medicine through the infinity of Time. To em-
ploy guiding principles represented by the “good practices 
of now”. To reinforce the benefits of the past and prevent 
the repetition of wrongdoing. To preserve the memory 
of the winding advances in the frontier of knowledge. To 
appreciate the impact of technological innovation on the 
quality of human life. To reveal the mutability of the ethi-
cal meaning of negligence and imprudence. Hence, it is 
useful to know the history of the knowledge of a disease.
Infective endocarditis was 100% fatal until three gener-
ations past – thus, to our great-grandparents. Research and 
clinical observations motivated by restlessness, creativ-
ity and collaboration supported the diagnostic and thera-
peutic progress in the second half of the 20th century that 
granted rapid applicability to the evidence on the pathog-
eny slowly accumulated throughout the preceding cen-
turies.  e necropsy pathognomonic vegetation became 
visible in vivo, showing how much the art of putting into 
practice the available scientific information is asymmet-
ric in Time. 
What can be remarkable, deserving attention in the 
history of infective endocarditis? Which steps contributed 
to reveal the unveiled of the clinical manifestation and the 
disease control? How did the information connections 
that were the basis of the current knowledge occur? 
In the conuence of the anatomopathological view of 
the 18th and 19th centuries with the subsequent acknowl-
edgement of germs, there were occasional reformulations 
in the disease concept, with dierent views in certain 
countries. 
 e clinical and pathogenic pieces fitted aer some 
comings and goings. It was necessary to carry out adapta-
tions in the current practice to construct a nosological iden-
tity that would gather the multiplicity of clinical expressions 
based on observed abnormalities. A crucial question was 
how much a clinical sign meant a disease and to what extent 
inammations in distinctive tissues could share the same 
symptoms. Infective endocarditis contributed very much to 
clarify the biopsychosocial bases of current Medicine. 
PIONEERING ASPECTS1,2
è e disclosure of infective endocarditis is contemporary 
to the discovery of Brazil. In the beginning of the Mod-
ern Age, the renowned physicians were humanists, highly 
esteemed literate men and used human dissection as the 
means to acquire new information on organs that could 
cause the clinical manifestations that were carefully writ-
ten down, waiting for the spontaneous course of evolution 
of the intractable disease. 
Jean François Fernel (1497-1558) was a French phy-
sician, alias the “modern Galen”, who cared for Henry II 
and queen Catherine de Medicis, who is also the astron-
omer-eponym of the lunar crater Fernelius, and became 
a prominent figure in history for having demonstrated a 
high synthesis capacity on bedside observations. He made 
the first comments regarding the clinical aspects of infec-
tive endocarditis. 
A new mark occurred years later, when the also French-
man Lazare Rivière (1589-1655) observed excrescences 
that were similar in size to a hazelnut, obstructing the leè 
ventricular outèow tract in a patient with a clinical picture 
that included cardiac arrhythmia, dyspnea and edema. 
Sixty years passed until Giovanni Maria Lancisi (1654-
1720) wrote that the small èesh nodules were valve tissue 
projections and not simple appositions. History progresses 
for over a century and in the beginning of the 19th century, 
Jean Nicolas Corvisart (1755-1821) minted the term “veg-
etation” for the èorescence that resembled the syphilis cau-
lièower. Years later, Jean-Baptiste Bouillaud (1796-1881) 
established a correlation between “typhoid” endocarditis 
and what he called acute rheumatoid arthritis. A little later, 
William Senhouse Kirkes (1822-1864) noted down that 
fragments of valve vegetations were found in the cerebral 
artery, kidneys and spleen in cases that had fever, heart 
murmur and purple skin spots, in addition to observing 
skin nodules, later called “Osler nodules” by Emanuel Lib-
man (1872-1946). In the second half of the 19th century, 
renowned clinicians such as Jean-Martin Charcot (1825-
1893) and Alfred Vulpian (1826-1887) understood that 
hyperthermia, chills and splenomegaly were symptoms 
of typhoid endocarditis, attributed to poisoning by a poi-
son produced in the diseased endocardium. Subsequently, 
Emmanuel Winge (1817-1894) described finding “para-
sitic microorganisms” in aortic valve vegetation around 
one month aè er a skin suppuration episode and Hjalmar 
Heiberg (1837-1897) recorded a case of endocarditis af-
ter puerperal fever. è e infective endocarditis secrets had 
started to be disclosed and could support theories. 
è e idea of a point of entry and transportation by blood 
èow was reinforced by Edwin Klebs (1834-1913) based on 
the presence of valve vegetation microorganisms in 27 
necropsies. A matter of concern was whether the presence 
of microorganisms was the cause or the consequence of 
valve vegetations. 
è e idea of valvular lesion as a predisposing factor was 
the missing factor to clear out the doubts. Still in the 19th 
century, Ottomar Rosenbach (1851-1907) and Karl Koes-
ter (1843-1904) observed that valvular impairment was 
the preceding factor that favored the development of in-
fective endocarditis. 
In the next-to-last decade of the 19th century, Hugo 
Ribbert (1855-1920) performed experiences of infective 
endocarditis induction. He injected Staphylococcus aureus 
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cultured in potatoes into rabbits and identified bacterial 
colonies over particles on the surface of heart valves, es-
pecially in the chordae tendineae of the mitral valve. In the 
same year, WK Wyssokowitsch (1854-1912) obtained 
the colonization of bacteria injected into the bloodstream 
of rabbits aer previous scarification of the aortic valve via 
the carotid artery. Based on the collection of experiments 
in animals of the time, two conclusions were drawn: a) the 
anteriority of a nonbacterial thrombotic endocardiopathy; 
b) the colonization of this substrate by circulating bacteria. 
 e 19th century ends associating valvular lesion, point 
of entry and circulation of microorganisms, fever and ex-
tra-cardiac manifestations under the synthetic diagnosis 
of infective endocarditis. 
THE CONTRIBUTION OF AN EPONYM3-5
William Bart Osler (1849-1919) is the eponym linked to 
infective endocarditis in general (Osler’s disease) and one 
of its peripheral manifestations (Osler’s nodes). He was a 
physician, famous for his triple nationality – a Canadian, 
he initially practiced in the United States of America and 
then in England – his name has been strongly associated 
with the education of young physicians. Osler was not a 
“parlor” physician and his knowledge, based on his being 
a good observer, contributed to construct a unified view of 
infective endocarditis. 
Osler perceived that there were simpler cases and more 
complex ones, and therefore, used discriminative terms 
such as ulcerative, malignant, septic and pyemic. He estab-
lished that blood elements such as fibrin and platelets de-
posited on the damaged endocardium – substrate of non-
bacterial thrombotic endocardiopathy – and constituted 
the nucleus of vegetation, devaluing the concept that it de-
pended on secretions from the endocardium. Osler called 
attention to the diversity of microorganisms involved in the 
vegetation and collected evidence in favor of the primary 
characteristic of the presence of germs in the etiopathogeny 
of infective endocarditis at a time when the detection of liv-
ing germs in blood cultures was incipient. 
Osler made it clear in his expositions that the infective 
endocarditis was a disease to be suspected in cases of fever 
and sudoresis; that it had a morphological basis related to 
the very high frequency of valvular lesion, which tended to 
be aggravated by infection; that it presented an evolution 
of weeks with extra-cardiac complications associated with 
the phenomenon of migration of elements involved in the 
endocardium, with the manifestation of petechiae, retinal 
hemorrhage, hematuria, splenomegaly, lower-limb embo-
lism and multiple-organ infarction. What currently seems 
to be simple had to be organized just like a database by an 
enthusiast of bedside learning. 
In the last decade of the 19th century, Osler reported his 
clinical experience with a woman that had a systolic mur-
mur associated with pre-existing mitral failure, knee and 
ankle edema and was eupneic only at rest.  e patient re-
ported that in the beginning of the disease, small spots ap-
peared on the hands and feet and also in the arms and face, 
which resembled “beehives”; they kept on appearing with 
an erythematous characteristic, some as small as pea and 
others as large as nickel, painful and that had a white dot in 
the center.  e manifestations disappeared in a few hours 
and never persisted until the night of the day when they 
appeared.  ey were not plentiful and sometimes were ob-
served at the fingertips, which became transitorily swollen. 
 e description of the nodes made Osler an eponym. 
Stimulated by Osler’s presentations, Lord  omas 
Jeeves Horder (1871-1955)5, a physician of the sover-
eigns of England, who taught that keeping doubts on the 
diagnosis was essential for preventing misconceptions – 
in fact, the necessary concern with self-second opinion 
means that doubts arise more from knowledge than from 
ignorance – published a collection of 150 cases of infec-
tive endocarditis, with illustrations of pathological lesions, 
in the first decade of the 20th century. During the estab-
lishment of infective endocarditis as a nosological entity, 
Horder emphasized the pre-existence of valvulopathy and 
congenital cardiopathy, the importance of the oral and in-
testinal points of entry, the occurrence of mycotic aneu-
rysm, the presence of splenomegaly and the identification 
of streptococcal etiology in more than 60% of the cases 
confirmed through necropsies. 
Horder recognized five types of infective endocarditis: 
1 – latent; 2- fulminant; 3- acute; 4- chronic and 5- sub-
acute, a modality that corresponded to 70% of the cases. 
PERSPECTIVES OF CURE6,7
 e physician started to know more about infective endo-
carditis, but Medicine did not have e cient therapeutic 
methods. In the 1930s, some therapeutic attempts with 
hyperpyrexia induction led to the conclusion that “…in 
spite of the increase in the cell reactions and the host’s de-
fense processes, Streptococcus viridans seems to resistant to 
high body temperatures that are safe for human body exposi-
tion…” (EP9).
Antibiosis (in opposition to symbiosis) is a term mint-
ed by Jean Paul Vuillemin (1861-1932), in 1889, for an-
tagonism eects of living beings in general and the term 
“antibiotic” was initially employed by Selman-Abraham 
Waksman (1888-1973) in 1942, adapting it to a substance 
produced by microorganisms that antagonizes the devel-
opment of other microorganisms.  e hope for the cure of 
infective endocarditis was born. 
In the beginning of the 1940s, sulfanilamide, a synthet-
ic compound, started to be used in infective endocarditis 
and determined some reports of therapeutic success, al-
though most cases showed a transient benefit and subse-
quent fatal progression.  is was the first clinical evidence 
that the bacteria located in the endocardium could be 
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aected. Great hope was brought by Lichtman and Bier-
man, when they reported the cure of infective endocar-
ditis in four (16%) of 25 cases, through the combined use 
of sulfanilamide and hyperpyrexia. One of the points of 
discussion was the strategy of hyperpyrexia sessions – at 
least eight sessions on alternate days, leading to an axil-
lary temperature of 40°C for approximately, at least, five 
hours. Early diagnosis and treatment seemed to be factors 
of inuence, regarding the response to the combined treat-
ment. Still during the 1940s, a collection of 200 cases of 
sulfonamide use (sulfanilamide, sulfapyridine, and sulfa-
thiazole) presented 12 (6%) cases of cure. For some time, 
some authors believed that the association of heparin, hy-
perthermia and intravenous use of vaccine against typhoid 
fever was e cient. 
Aer penicillin availability became universal, thanks 
to the pioneer eorts of Englishmen such as Nobel-prize 
winner Howard Florey (1898-1968) and Americans such 
as Martin Henry Dawson (1896-1945), the treatment of in-
fective endocarditis started an e ciency ascension. From 
1944/1945 onward, the antibiotic therapy of infective en-
docarditis accumulated rapid experience and success. 
In 1945, Dawson and Hunter concluded that infective 
endocarditis by Streptococcus viridans could be treated 
with penicillin.  e authors used from 80,000 to 500,000 
units daily of penicillin, by IV or IM route, in fractionated 
doses, in general every three hours, for periods of 10 to 62 
days, in most cases associated with heparin as therapeutic 
adjuvant.  ree months aer completing the treatment, 14 
(70%) of the 20 patients were free of evidence of infection. 
One curiosity is the addendum of the original article that 
includes seven more patients (six cases resulted in infec-
tion control), with the observation that the continuous 
intramuscular infusion of penicillin had been better toler-
ated by the patient than the IV infusion, but the technique 
restricted the use of heparin. As time went by, penicillin 
became pure and allowed the safe administration of larger 
doses for longer periods of time in cases of infective endo-
carditis by bacteria that were sensitive to it. 
As usually happens, benefits on the natural history of 
a disease give the opportunity for the development of sur-
vival with new clinical expressions. 
  ree aspects of the therapeutic e ciency with prog-
nostic implications became the cause of growing concern: 
a) the evolution of the cardiac area; b) worsening in the 
capacity for physical eorts; c) evolution of the morpho-
logical severity of the pre-existing valvular lesion. One 
piece of information was clear, from the accurate observa-
tion that characterized the time and which remains valid: 
“…infective endocarditis rarely occurs in the presence of se-
vere rheumatic cardiopathy…”
In other words, the decrease in mortality to approxi-
mately 30% (penicillin-dependent fact) brought worries 
concerning surviving the infection and quality of life 
impairment due to the worsening in the previous cardi-
opathy. As a consequence, the deleterious morphological 
eects of infective endocarditis increased the research on 
the foundations of the direct intervention on the severe 
and symptomatic valvular lesion. 
SURGERY AT THE STUDY PHASE OF INFECTIVE ENDOCARDITIS8
In the 1960s, it was established that infective endocarditis 
was a curable disease.  e perspective of controlling the 
infection increased the physician’s restlessness regarding 
the cases that did not respond to antibiotics. Some thought 
about a direct intervention on the heart to remove the in-
fected tissue, but the concept of imprudence was strong, 
in relation to operating on a patient with fever and heart 
failure. Andrew G. Wallace et al.8 at Duke University, un-
derstood that the removal of the infected valve and its sub-
stitution by a valve prosthesis constituted an approach on 
the clinical manifestation cause and therefore, fever and 
heart failure were not exactly comorbidities that added a 
surgical risk. 
A 45-year-old construction worker, with endocarditis 
by Klebsiella sp. that did not respond to colicimin and ka-
namycin and clear worsening in the aortic failure, became 
the first patient to have visible vegetation in vivo, directly 
in a Surgical Center, as well as perforations of right and 
le coronary leaets.  e implantation of a Starr-Edwards 
prosthesis resulted in a febrile patient, with negative blood 
cultures and slight paravalvular failure with no peripheral 
signs of aortic failure that persisted at the follow-up car-
ried out at 15 months of postoperative evolution.   e au-
thors emphasized that the absence of the valvular annulus 
involvement was a factor of success, as it was a sign that 
there was no infection beyond the excised valve. 
 e assistential innovation that dismissed a research 
project and consequent ethical evaluation marked the be-
ginning of the association of valvular prosthesis and infec-
tive endocarditis, both as therapeutics and etiopathogeny 
(endocarditis in prosthesis). Subsequently, the routine sur-
gical indication in cases of infective endocarditis in cases 
with CHF grade III/IV (the most common recommenda-
tion) reduced mortality from 90% to 10%. 
ECHOCARDIOGRAPHY DISCLOSING VEGETATION9
 e history of the echocardiography started with the use 
of ultrasonography to evaluate mitral failure aer com-
missurotomy and pericardial eusion, as a consequence of 
the studies by Inge Edler (1911-2001) and Hellmuth Hertz 
(1920-1990), in the 1950s and the subsequent contribution 
of Harvey Feigenbaum, the “Father of Echocardiography”. 
 e 1970s gathered the publication of articles empha-
sizing the disclosure of vegetation by M-mode echocar-
diography. In 1980, JA Stewart et al.9, from Duke Univer-
sity, summarized the state-of-the-art of the time, aer they 
identified 54% of positive signs of vegetation at the echo-
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cardiography: “... although it is a good method to document 
the presence or the absence of infective endocarditis, it does 
not seem to be reasonable to use the echocardiography as a 
routine diagnostic method; as only half of the patients that 
meet  the clinical criteria manifests echocardiographic signs; 
moreover, the vegetation does not regress rapidly and thus, 
the echocardiography might have a low diagnostic power in 
a patient with a history of infective endocarditis…”.
 irty years aer these words by Stewart et al.9 one 
verifies that the accumulation of experience determined a 
remarkable evolution in the support of the diagnostic ra-
tionale of infective endocarditis by joining the traditional 
clinical data and images and calculations determined by 
technological advancement in echocardiography (two-di-
mensional, Doppler and transesophageal).  e term sub-
acute endocarditis practically disappeared, due mostly to a 
faster diagnosis supported by the echocardiographic iden-
tification of vegetation in cases with fever and cardiopathy. 
In the 1990s, Duke University gave another magnifi-
cent contribution to the knowledge of infective endocar-
ditis through a diagnostic systematization that elevated 
echocardiography as a determinant method of a major 
criterion. 
FROM CLINICALLY POSSIBLE TO CLINICALLY DEFINED10-12
As the disease has a high diversity of presentations, the 
creation of solid criteria was the target of many research-
ers that realized that any increase in sensitivity caused a 
decrease in specificity and vice-versa. 
In 1981, Fordham Charles von Reyn et al.10 distributed 
123 cases as defined infective endocarditis (19), probable 
(44), possible (41) and rejected (19).  e specifications of 
each category were useful; however, it soon became out-
dated, due to two main reasons: a) the diagnosis of defined 
was based on anatomopathological data and therefore, 
the clinician, was actually treating a possible or probable 
case; b) the studies preceded the introduction of the two-
dimensional echocardiography and the Doppler use. 
For years, those who cared for cases of infective endo-
carditis incorporated the echocardiography in the support 
of the clinical diagnosis of infective endocarditis at the 
bedside, until 1994, when David Durack et al.11, at Duke 
University, systematized and published the possibility of 
dismissing the identification of vegetation in favor of the 
pathological anatomy as the basis for the classification of 
defined infective endocarditis, substituting it for the echo-
cardiographic image.  us, it was reduced to three catego-
ries: defined, possible and rejected. 
 e Duke University criteria used the strategy utilized 
by  omas Duckett Jones (1899-1954) of subdividing the 
criteria in major and minor ones. 
 e echocardiography and the blood culture started 
to have identical diagnostic hierarchy as major criteria for 
the diagnosis of infective endocarditis, with evident gain 
in sensitivity. Two major criteria or one major and three 
minor criteria gave the clinician the basis to treat “a cer-
tainty” and not a possibility of infective endocarditis. 
Several studies validated the new criteria; however, 
some gaps were perceived. In 2000, Jennifer S. Li, a pro-
fessor of Pediatrics from Duke University and colleagues12 
completed the outstanding advancement in the frontier of 
knowledge on infective endocarditis in the 20th century, 
presenting a perfected version of the 1994 criteria from 
Duke University. 
 e main improvements were: a) possible endocarditis 
based on at least one major and one minor criterion or 
three minor criteria; b) elimination of “echocardiographic 
data consistent with infective endocarditis, but not achiev-
ing a major criteria”, due to the use of the transesophageal 
method; c) upgrade in bacteremia by Staphylococcus aure-
us to the condition of major criterion, both in nosocomial 
infections as well as those associated with an eradicable 
source of infection; d) positive serology for Q fever start-
ed to be a major criteria with the same weight of positive 
blood culture. 
ANTIBIOTIC PROPHYLAXIS USE13
In approximately 60 years, there have been big changes in 
antibiotic prophylaxis recommendations for infective en-
docarditis. Time has shortened doses, restricted the num-
ber of patients considered at risk and limited the inducing 
procedures.  e lack of controlled studies justifies the var-
ied behavior in relation to such a severe disease. 
In 1955, intramuscular penicillin was injected into the 
patient 30 minutes before dental procedures. In 1957, oral 
penicillin was administered four times a day for two days 
before, on the day and for two days aer the dental manip-
ulation.  In 1960, the dose was a single daily one of 600,000 
units of crystalline penicillin, for five days. In 1965, the 
first dose of penicillin was given one to two hours before 
the procedure.  In 1977, intramuscular penicillin was ap-
plied 30 to 60 minutes before the dental manipulation, fol-
lowed by eight doses of 500 mg of V penicillin every two 
hours. In 1984, the recommendation was 2g of penicillin 
V 60 minutes before the dental procedure, followed by 1g 
aer six hours. In 1990, 3g of oral amoxicillin was rec-
ommended, 60 minutes before the procedure, followed by 
1.5g aer six hours. In 1997, the dose of amoxicillin was 
reduced to 2g, 60 minutes before the dental procedure, in 
a single dose.
HOMAGE TO A BRAZILIAN 
In the decades of 1960/1970, cases of fever and cardi-
opathy, especially in young individuals, determined the 
preferential diagnostic suspicion of rheumatic fever (RF) 
activity among us. In many cases, infective endocarditis 
was not even suspected, considering that microbiological 
support was limited. 
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 e need to give more attention to the dierential di-
agnosis of RF with infective endocarditis14 was introduced 
to Brazilian students of Cardiology by a professor that 
cannot be le out of any historical record on infective en-
docarditis carried out in Brazil, and who was one of the 
Brazilian Society of Cardiology founders, in 1943: Luiz 
“I believe in Medicine, which is a continuous act of im-
provement” Venere Décourt (1911-2007).
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